NC State researchers using soy in canine cancer treatment
Raleigh, N.C. -- A molecule found in soy that has proved toxic to a wide variety of human cancer cells is now being studied to determine if it could also inhibit the growth of canine lymphoma cells.
Raleigh, N.C.
-- Genistein, a molecule found in soy that has proved toxic to a wide variety of human cancer cells, is now being studied to determine if it could also inhibit the growth of canine lymphoma cells.
Dr. Steven Suter, assistant professor of oncology at North Carolina State University, says his study has shown that a commercially available form of genistein called GCP was effective in killing canine lymphoid cells in a laboratory setting and can be absorbed into a dog's bloodstream easily. GCP can help chemotherapy work more effectively and faster, which translates to less stress to the patient, Suter concludes.
The hope is that veterinarians will put the inexpensive treatment, a dietary supplement that can be administered in pill form, to use as a canine cancer therapy, Suter says.
UN, WHO address public health concern over avian flu transmission to humans
April 18th 2024Veterinary professionals working with certain animals are advised to take precautionary steps to minimize risk of infection, while researchers in Texas study potential H5N1 vaccines, antivirals, and antibody therapies for humans
Read More
